CEFIXIME
- Product NDC
- 68180-423
- 11-digit product format
- 681800423
- Labeler code
- 68180
- Product ID
- 68180-423_735f86f4-369c-4f5a-adbe-7dacea2e27b4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFIXIME
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- NDA203195
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-10-14
- Substance
- CEFIXIME
- Active strength
- 400 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEFIXIME
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFIXIME | 400 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 97I1C92E55 |
| Rxcui | 309058, 409823, 419849 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-423-08 | CEFIXIME | 50 in 1 BOTTLE | CAPSULE | 50 | | 14 |
| 68180-423-11 | CEFIXIME | 1 in 1 CARTON | CAPSULE | 1 | | 14 |
| 68180-423-11 | CEFIXIME | 10 in 1 BLISTER PACK | CAPSULE | 10 | | 14 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFIXIME | ACTIVE INGREDIENT | 97I1C92E55 | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
| CEFIXIME ANHYDROUS | ACTIVE MOIETY | XZ7BG04GJX | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
| STRAWBERRY | INACTIVE INGREDIENT | 4J2TY8Y81V | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | CEFIXIME POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-423 | CEFIXIME POWDER, FOR SUSPENSION CEFIXIME CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 12 | Current NDC, Legacy NDC, 3 package rows | 20250130_6d68dbd9-7d75-4ff1-91db-79ff8ae879ec.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-423-08 | 68180042308 | 50 CAPSULE in 1 BOTTLE (68180-423-08) | 50 capsule | 2020-10-14 | 0000-00-00 | No | No | Current |
| 68180-423-11 | 68180042311 | 1 BLISTER PACK in 1 CARTON (68180-423-11) / 10 CAPSULE in 1 BLISTER PACK | 1 blister pack | 2020-10-14 | 0000-00-00 | No | No | Current |